Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARNEROS-1: Intra-arterial alfimeprase for acute ischemic stroke
2007-005254-24Phase 2Terminated
- Sponsor
- Nuvelo
- Start
- Jan 2008
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alfimeprase in ischemic stroke, sponsored by Nuvelo. Primary endpoint: Primary safety endpoint. Started Jan 2008; status: terminated.
02
Drugs
alfimeprase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2007-005254-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005254-24.